PGT Experience: How IVF Patients Can Level Up Their Embryos

Allyn Rose shares her IVF journey with PGT-M and PGT-A testing, revealing how 3 out of 9 embryos cleared both genetic screens. The process, involving egg retrieval, biopsy, and a three-week wait for results, helped her and her partner secure four healthy embryos to reduce her family’s genetic disease risk.

---

Key Takeaways

PGT-M Explained: Reducing Hereditary Disease Risk

PGT-M (Preimplantation Genetic Testing for Monogenic disorders) allows couples to screen embryos for single-gene mutations like BRCA 1/2. Allyn used this to eliminate the risk of passing her rare genetic disorder, which caused three uncles to die.

The PGT-A Process: Screening for Chromosomal Abnormalities

PGT-A tests embryos for aneuploidy (chromosome count errors). Allyn’s embryos were biopsied at the blastocyst stage, with results identifying 3 chromosomally normal embryos after a 3-week wait.

The Two Week Wait: Navigating PGT Results Timeline

PGT results typically take 14 days, but Allyn’s case took 21. This period involves emotional stress while waiting for genetic test outcomes to determine viable embryos for transfer.

PGT Success Rates: 3/9 Embryos Cleared for Transfer

Of 9 biopsied embryos, 3 passed both PGT-M and PGT-A tests. Combined with a prior IVF cycle, Allyn and her partner now have 4 genetically healthy embryos available for transfer.

Genetic Testing for IVF: Why It’s Essential for High-Risk Patients

For individuals with hereditary conditions, PGT is a critical tool to prevent passing on genetic diseases. Allyn’s decision to use PGT provided peace of mind after losing relatives to her genetic disorder.

---

Source: Read full article